ConvaTec Group (LSE:CTEC) Current Accrued Expense : £0 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group Current Accrued Expense?

ConvaTec Group's Current Accrued Expense for the quarter that ended in Dec. 2023 was £0 Mil.

ConvaTec Group Current Accrued Expense Historical Data

The historical data trend for ConvaTec Group's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group Current Accrued Expense Chart

ConvaTec Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

ConvaTec Group Semi-Annual Data
	Dec13	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial														-	-	-	-	-

ConvaTec Group Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

ConvaTec Group Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

ConvaTec Group (LSE:CTEC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (LSE:CTEC) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

CNVVF:USA CNVVY:USA CTECl:UK

Address

23 Forbury Road, 3 Forbury Place, Reading, GBR, RG1 3JH

Website

https://www.convatecgroup.com

Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.